Goldentree Asset Management LP bought 150,652 shares of Keenova Therapeutics plc at $89.25 to $91.00 a share (average $90.65) in 2 transactions, worth $13.7M in total between Nov 9, 2026 and Nov 10, 2026. Shares held after the trade: 9,026,195 (+1.4%).
Goldentree Asset Management LP bought 295,716 shares of Keenova Therapeutics plc at $89.25 a share, worth $26.4M in total between Nov 5, 2026 and Nov 6, 2026. Shares held after the trade: 8,875,543 (+1.7%).
Goldentree Asset Management LP bought 137,000 shares of Keenova Therapeutics plc at $90.00 a share, worth $12.3M in total on Oct 14, 2026. Shares held after the trade: 8,579,827 (+1.6%).
Goldentree Asset Management LP bought 463,000 shares of Keenova Therapeutics plc at $91.00 a share, worth $42.1M in total on Sep 24, 2026. Shares held after the trade: 8,442,827 (+5.8%).